Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization... Revascularization in grey-zone FFR 1619 Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, 27. Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nyga ˚rd O, Nilsen DW, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Guidelines. Third universal definition of myocardial infarction. Eur Heart J 2012; Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT 33:2551–2567. Investigators. Drug-eluting or bare-metal stents for coronary artery disease. 20. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per inde- N Engl J Med 2016;375:1242–1252. pendent variable in proportional hazards regression analysis. II. Accuracy and . 28. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits precision of regression estimates. J Clin Epidemiol 1995;48:1503–1510. PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life 21. Ho D, Imai K, King G, Stuart E. MatchIt: nonparametric preprocessing for para- practice (COMPARE): a randomised trial. Lancet 2010;375:201–209. metric causal inference. J Stat Softw 2011;42:1–28. . 29. Johnson NP, Toth GG, Lai D, Zhu H, Acar G, Agostoni P, Appelman Y, Arslan F, 22. Austin PC. Optimal caliper widths for propensity-score matching when estimat- Barbato E, Chen SL, Di Serafino L, Dominguez-Franco AJ, Dupouy P, Esen AM, ing differences in means and differences in proportions in observational studies. Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jimenez-Navarro MF, Katritsis DG, Pharm Stat 2011;10:150–161. Kocaman SA, Koo BK, Lopez-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, 23. Hansen B, Bowers J. Covariate balance in simple, stratified and clustered com- . Oud N, Puymirat E, Rieber J, Rioufol G, Rodes-Cabau J, Sedlis SP, Takeishi Y, parative studies. Stat Sci 2008;23:219–236. Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne 24. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van B, Gould KL. Prognostic value of fractional flow reserve: linking physiologic se- Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients . verity to clinical outcomes. J Am Coll Cardiol 2014;64:1641–1654. with prior myocardial infarction. Circulation 2001;104:157–162. 30. Depta JP, Patel JS, Novak E, Gage BF, Masrani SK, Raymer D, Facey G, Patel Y, 25. Samady H, Lepper W, Powers ER, Wei K, Ragosta M, Bishop GG, Sarembock IJ, Zajarias A, Lasala JM, Amin AP, Kurz HI, Singh J, Bach RG. Risk model for esti- Gimple L, Watson DD, Beller GA, Barringhaus KG. Fractional flow reserve of mating the 1-year risk of deferred lesion intervention following deferred revascu- infarct-related arteries identifies reversible defects on noninvasive myocardial . larization after fractional flow reserve assessment. Eur Heart J 2015;36:509–515. perfusion imaging early after myocardial infarction. J Am Coll Cardiol 2006;47: 31. Doh JH, Nam CW, Koo BK, Park SH, Lee JH, Han JK, Yang HM, Lim HS, Yoon 2187–2193. MH, Cho YK, Hur SH, Lee SY, Kim HS, Tahk SJ. Long-term patient-related and 26. Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: lesion-related outcomes after real-world fractional flow reserve use. J Invasive can we live without it? Eur Heart J 2013;34:1335–1344. Cardiol 2015;27:410–415. doi:10.1093/eurheartj/ehx547 Corrigendum Online publish-ahead-of-print 12 September 2017 ................................................................................................ .................................................................. Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study’. Eur Heart J (2017) doi:10.1093/eurheartj/ehx512. The authors of the above article wish to inform readers that the following acknowledgement was missing from the paper as first published: Prof Adrian Banning is partially supported by the NIHR Biomedical Research Centre, Oxford. The article has now been corrected online. V The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/18/1619/4139705 by Ed 'DeepDyve' Gillespie user on 21 June 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

European Heart Journal , Volume Advance Article (18) – Sep 12, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/corrigendum-to-clinical-outcomes-of-state-of-the-art-percutaneous-IMZYDQd6vI
Publisher
Oxford University Press
Copyright
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology.
ISSN
0195-668X
eISSN
1522-9645
D.O.I.
10.1093/eurheartj/ehx547
Publisher site
See Article on Publisher Site

Abstract

Revascularization in grey-zone FFR 1619 Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, 27. Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nyga ˚rd O, Nilsen DW, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Guidelines. Third universal definition of myocardial infarction. Eur Heart J 2012; Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT 33:2551–2567. Investigators. Drug-eluting or bare-metal stents for coronary artery disease. 20. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per inde- N Engl J Med 2016;375:1242–1252. pendent variable in proportional hazards regression analysis. II. Accuracy and . 28. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits precision of regression estimates. J Clin Epidemiol 1995;48:1503–1510. PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life 21. Ho D, Imai K, King G, Stuart E. MatchIt: nonparametric preprocessing for para- practice (COMPARE): a randomised trial. Lancet 2010;375:201–209. metric causal inference. J Stat Softw 2011;42:1–28. . 29. Johnson NP, Toth GG, Lai D, Zhu H, Acar G, Agostoni P, Appelman Y, Arslan F, 22. Austin PC. Optimal caliper widths for propensity-score matching when estimat- Barbato E, Chen SL, Di Serafino L, Dominguez-Franco AJ, Dupouy P, Esen AM, ing differences in means and differences in proportions in observational studies. Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jimenez-Navarro MF, Katritsis DG, Pharm Stat 2011;10:150–161. Kocaman SA, Koo BK, Lopez-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, 23. Hansen B, Bowers J. Covariate balance in simple, stratified and clustered com- . Oud N, Puymirat E, Rieber J, Rioufol G, Rodes-Cabau J, Sedlis SP, Takeishi Y, parative studies. Stat Sci 2008;23:219–236. Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne 24. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van B, Gould KL. Prognostic value of fractional flow reserve: linking physiologic se- Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients . verity to clinical outcomes. J Am Coll Cardiol 2014;64:1641–1654. with prior myocardial infarction. Circulation 2001;104:157–162. 30. Depta JP, Patel JS, Novak E, Gage BF, Masrani SK, Raymer D, Facey G, Patel Y, 25. Samady H, Lepper W, Powers ER, Wei K, Ragosta M, Bishop GG, Sarembock IJ, Zajarias A, Lasala JM, Amin AP, Kurz HI, Singh J, Bach RG. Risk model for esti- Gimple L, Watson DD, Beller GA, Barringhaus KG. Fractional flow reserve of mating the 1-year risk of deferred lesion intervention following deferred revascu- infarct-related arteries identifies reversible defects on noninvasive myocardial . larization after fractional flow reserve assessment. Eur Heart J 2015;36:509–515. perfusion imaging early after myocardial infarction. J Am Coll Cardiol 2006;47: 31. Doh JH, Nam CW, Koo BK, Park SH, Lee JH, Han JK, Yang HM, Lim HS, Yoon 2187–2193. MH, Cho YK, Hur SH, Lee SY, Kim HS, Tahk SJ. Long-term patient-related and 26. Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: lesion-related outcomes after real-world fractional flow reserve use. J Invasive can we live without it? Eur Heart J 2013;34:1335–1344. Cardiol 2015;27:410–415. doi:10.1093/eurheartj/ehx547 Corrigendum Online publish-ahead-of-print 12 September 2017 ................................................................................................ .................................................................. Corrigendum to: ‘Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study’. Eur Heart J (2017) doi:10.1093/eurheartj/ehx512. The authors of the above article wish to inform readers that the following acknowledgement was missing from the paper as first published: Prof Adrian Banning is partially supported by the NIHR Biomedical Research Centre, Oxford. The article has now been corrected online. V The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/18/1619/4139705 by Ed 'DeepDyve' Gillespie user on 21 June 2018

Journal

European Heart JournalOxford University Press

Published: Sep 12, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off